1. Home
  2. TRDA vs STKL Comparison

TRDA vs STKL Comparison

Compare TRDA & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • STKL
  • Stock Information
  • Founded
  • TRDA 2016
  • STKL 1973
  • Country
  • TRDA United States
  • STKL United States
  • Employees
  • TRDA N/A
  • STKL N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • STKL Precious Metals
  • Sector
  • TRDA Health Care
  • STKL Basic Materials
  • Exchange
  • TRDA Nasdaq
  • STKL Nasdaq
  • Market Cap
  • TRDA 350.5M
  • STKL 409.0M
  • IPO Year
  • TRDA 2021
  • STKL N/A
  • Fundamental
  • Price
  • TRDA $9.92
  • STKL $3.33
  • Analyst Decision
  • TRDA Strong Buy
  • STKL Buy
  • Analyst Count
  • TRDA 2
  • STKL 2
  • Target Price
  • TRDA $24.50
  • STKL $9.00
  • AVG Volume (30 Days)
  • TRDA 293.9K
  • STKL 2.0M
  • Earning Date
  • TRDA 11-06-2025
  • STKL 11-05-2025
  • Dividend Yield
  • TRDA N/A
  • STKL N/A
  • EPS Growth
  • TRDA N/A
  • STKL N/A
  • EPS
  • TRDA N/A
  • STKL 0.01
  • Revenue
  • TRDA $61,520,000.00
  • STKL $792,436,000.00
  • Revenue This Year
  • TRDA N/A
  • STKL $12.80
  • Revenue Next Year
  • TRDA N/A
  • STKL $7.91
  • P/E Ratio
  • TRDA N/A
  • STKL $417.60
  • Revenue Growth
  • TRDA N/A
  • STKL 11.95
  • 52 Week Low
  • TRDA $4.93
  • STKL $3.33
  • 52 Week High
  • TRDA $21.79
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 76.59
  • STKL 17.16
  • Support Level
  • TRDA $8.17
  • STKL $3.69
  • Resistance Level
  • TRDA $9.12
  • STKL $4.37
  • Average True Range (ATR)
  • TRDA 0.72
  • STKL 0.26
  • MACD
  • TRDA 0.20
  • STKL -0.07
  • Stochastic Oscillator
  • TRDA 87.16
  • STKL 0.50

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: